Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage.
Graefes Arch Clin Exp Ophthalmol
; 257(10): 2119-2125, 2019 Oct.
Article
in En
| MEDLINE
| ID: mdl-31286206
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Visual Acuity
/
Patient Compliance
/
Insurance Coverage
/
Receptors, Vascular Endothelial Growth Factor
/
Diabetic Retinopathy
/
Ranibizumab
/
Macular Degeneration
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Graefes Arch Clin Exp Ophthalmol
Year:
2019
Document type:
Article
Affiliation country:
Austria
Country of publication:
Germany